Progyny (PGNY) Shares Outstanding (Diluted Average) (2020 - 2026)

Progyny (PGNY) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $84.8 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $84.8 million, down 5.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.8 million (down 5.1% YoY), and the FY2025 annual result was $89.9 million, down 5.85% from the prior year.
• Shares Outstanding (Diluted Average) eased to $84.8 million in Q1 2026 per PGNY's latest filing, from $89.9 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $101.1 million in Q1 2024 and troughed at $84.8 million in Q1 2026.
• A 5-year average of $96.1 million and a median of $99.7 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) gained 1.06% in 2023, then fell 11.62% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $100.0 million in 2022, then advanced by 0.72% to $100.7 million in 2023, then retreated by 5.19% to $95.4 million in 2024, then decreased by 5.85% to $89.9 million in 2025, then dropped by 5.68% to $84.8 million in 2026.
• Business Quant data shows PGNY's Shares Outstanding (Diluted Average) at $84.8 million in Q1 2026, $89.9 million in Q4 2025, and $90.2 million in Q3 2025.